Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
公司代码RPID
公司名称Rapid Micro Biosystems Inc
上市日期Jul 15, 2021
CEOSpignesi (Robert)
员工数量163
证券类型Ordinary Share
年结日Jul 15
公司地址25 Hartwell Avenue
城市LEXINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02421
电话19783493200
网址https://www.rapidmicrobio.com/
公司代码RPID
上市日期Jul 15, 2021
CEOSpignesi (Robert)